News
Nestle acquired Aimmune with high hopes that Palforzia would generate blockbuster sales as the first FDA-approved therapy for peanut allergy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback